Choi YJ, Kim DS, Sung YH, Kim DH, et al. Retraction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer. Cancer Res 2022 Aug 26:OF1. doi: 10.1158/0008-5472.CAN-22-2507.
PMID: 36018295